This is significant to consider...
We are often asked by shareholders, 'when can we expect a licensing deal with Big Pharma?'
There are no set rules, but the business model for many biotech companies is to aim to generate compelling Phase 2 data and then seek out a deal with Big Pharma either as a license or outright purchase. I am aware that shareholders are anxious to know where we are in that cycle, but at the moment we do not have anything bad or good to report and are focusing on generating data of interest to potential partners. We are pursuing a number of paths in highly competitive circumstances, which is the nature of out-licensing. It takes time, and it is fluid, and we will only communicate to the market when a deal is completed.
- Forums
- ASX - By Stock
- IMU
- Ann: Letter to Shareholders
Ann: Letter to Shareholders, page-12
-
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.2M |
Open | High | Low | Value | Volume |
5.2¢ | 5.2¢ | 5.0¢ | $1.098M | 21.50M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
97 | 7481668 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 1703097 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
89 | 5589588 | 0.050 |
23 | 1947956 | 0.049 |
19 | 1365961 | 0.048 |
8 | 2836679 | 0.047 |
15 | 1604916 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 1703097 | 4 |
0.052 | 3475772 | 11 |
0.053 | 1615148 | 7 |
0.054 | 1375711 | 7 |
0.055 | 1499783 | 10 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online